Synergistic efficacy of phage Henu10 with antibiotics against Shigella dysenteriae with insight into phage resistance and fitness trade-offs
Frontiers in Cellular and Infection Microbiology · 2024
DOI: 10.3389/fcimb.2024.1499325 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Jing Zhao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Gynaecology Department, Hua County People's Hospital, Anyang, China. Hauptthemen laut MEDLINE: Shigella dysenteriae, Anti-Bacterial Agents, Phage Therapy, Bacteriophages. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Postdoctoral Science Foundation, National College Students Innovation and Entrepreneurship Training Program, Science and Technology Department, Henan Province.
Abstract (Originalsprache)
Introduction
The irrational use of antibiotics has facilitated the emergence of multidrug- resistant Shigella spp ., undermining the effectiveness of the currently available antibiotics. Consequently, there is an urgent need to explore new approaches, with phage therapy emerging as a promising alternative.
Methods
In this study, we isolated a phage targeting Shigella dysenteriae from sewage samples using DLA methold, designated Henu10. The morphology, biological characteristics, genomic composition, and phylogenetic relationships of Henu10 were thoroughly characterized. To investigate the trade-off relationship between phage resistance and bacterial fitness, phage Henu10-resistant strains R6 and R11 were identified using continuous passage and bidirectional validation methods.
Results
Phage-resistant strains R6 and R11 exhibited impaired adsorption, increased sensitivity to temperature and pH stress, heightened susceptibility to certain antibiotics (such as ciprofloxacin and kanamycin), reduced biofilm-forming capacity, and diminished colonization ability in vivo compared to the wild-type strain.
Discussion
These results indicate that phage Henu10 may effectively control the pathogenic bacteria associated with S. dysenteriae , representing a promising new therapeutic option for treating S. dysenteriae infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gynaecology Department, Hua County People's Hospital, Anyang, China.
- Institute of Biomedical Informatics, School of Basic Medical Sciences, Henan University, Kaifeng, China.
- Department of Microbiology and Immunology, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt.
Förderung
- China Postdoctoral Science Foundation
- National College Students Innovation and Entrepreneurship Training Program
- Science and Technology Department, Henan Province
Zitieren
APA
Zhao, J., Chen, B., Wang, W., Kang, Y., Hu, E., Zhang, Y., Chen, H., Xu, X., Ji, X., Wang, Y., Teng, T., & Gomaa, S. E. (2024). Synergistic efficacy of phage Henu10 with antibiotics against Shigella dysenteriae with insight into phage resistance and fitness trade-offs. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1499325
Vancouver
Zhao J, Chen B, Wang W, Kang Y, Hu E, Zhang Y, et al. Synergistic efficacy of phage Henu10 with antibiotics against Shigella dysenteriae with insight into phage resistance and fitness trade-offs. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1499325
BibTeX
@article{Zhao2024,
author = {Zhao, Jing and Chen, Baohong and Wang, Weizhen and Kang, Yu and Hu, Erli and Zhang, Yuan and Chen, Huiling and Xu, Xiao and Ji, Xinying and Wang, Yuhan and Teng, Tieshan and Gomaa, Salwa E},
title = {Synergistic efficacy of phage Henu10 with antibiotics against Shigella dysenteriae with insight into phage resistance and fitness trade-offs},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2024},
doi = {10.3389/fcimb.2024.1499325}
}
EUVIMED